{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:17:33Z","timestamp":1792081053299,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.lfs.2022.120751","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T04:05:27Z","timestamp":1656648327000},"page":"120751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q\/tumor necrosis factor-related protein-3 and ATP citrate lyase"],"prefix":"10.1016","volume":"305","author":[{"given":"Mohamed M.","family":"Elseweidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E.","family":"Elesawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad M.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0005","first-page":"15","article-title":"HbA1C as a biomarker of non-alcoholic fatty liver disease: comparison with anthropometric parameters","volume":"9","author":"Masroor","year":"2021","journal-title":"J. Clin.Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.lfs.2022.120751_bb0015","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4254\/wjh.v13.i10.1203","article-title":"Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Alam","year":"2021","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0020","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2337\/dc18-2173","article-title":"Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes","volume":"42","author":"Pilemann-Lyberg","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lfs.2022.120751_bb0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3389\/fgene.2019.00945","article-title":"Heterogeneity in metabolic responses to dietary fructose","author":"Hou","year":"2019","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120751_bb0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/nu9040395","article-title":"Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review","volume":"9","author":"Caliceti","year":"2017","journal-title":"Nutrients"},{"issue":"11\u201312","key":"10.1016\/j.lfs.2022.120751_bb0040","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.nut.2010.02.014","article-title":"Fructose and metabolic diseases: new findings, new questions","volume":"26","author":"Tappy","year":"2010","journal-title":"Nutrition"},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0045","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jn\/nxac039","article-title":"Importance of carbohydrate quality: what does it mean and how to measure it?","volume":"152","author":"Campos","year":"2022","journal-title":"J. Nutr."},{"key":"10.1016\/j.lfs.2022.120751_bb0050","first-page":"3305","article-title":"The contribution of dietary fructose to non-alcoholic fatty liver disease","author":"Yu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0055","first-page":"490","article-title":"Fructose and liver function\u2013is this behind nonalcoholic liver disease?","volume":"18","author":"Jin","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0060","first-page":"1","article-title":"Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway","volume":"11","author":"Cho","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-physiol-021113-170343","article-title":"The molecular physiology of uric acid homeostasis","volume":"77","author":"Mandal","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.lfs.2022.120751_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109158","article-title":"Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): a clinical analysis and mechanistic study","volume":"117","author":"Xu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0075","doi-asserted-by":"crossref","first-page":"E1032","DOI":"10.1152\/ajpendo.00518.2020","article-title":"High uric acid induces liver fat accumulation via ROS\/JNK\/AP-1 signaling","volume":"320","author":"Xie","year":"2021","journal-title":"Am. J. Physiol.Endocrinol. Metab."},{"issue":"48","key":"10.1016\/j.lfs.2022.120751_bb0080","doi-asserted-by":"crossref","first-page":"40732","DOI":"10.1074\/jbc.M112.399899","article-title":"Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver","volume":"287","author":"Lanaspa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ijo.2009.259","article-title":"Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response","volume":"34","author":"Perez-Pozo","year":"2010","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijpo.238","article-title":"Oral fructose absorption in obese children with non-alcoholic fatty liver disease","volume":"10","author":"Sullivan","year":"2015","journal-title":"Pediatr. Obes."},{"issue":"8","key":"10.1016\/j.lfs.2022.120751_bb0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/nu10080981","article-title":"Sugar-sweetened soft drinks and fructose consumption are associated with hyperuricemia: cross-sectional analysis from the Brazilian longitudinal study of adult health (ELSA-Brasil)","volume":"10","author":"Siqueira","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.lfs.2022.120751_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110795","article-title":"Recent advances in fructose intake and risk of hyperuricemia","volume":"131","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0105","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.3390\/ijms15058713","article-title":"Role of mitochondria in nonalcoholic fatty liver disease","volume":"15","author":"Nassir","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.lfs.2022.120751_bb0110","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.clinbiochem.2012.03.024","article-title":"Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation","volume":"45","author":"Grattagliano","year":"2012","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0115","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1159\/000495384","article-title":"ATP citrate lyase and LncRNA NONMMUT010685 play crucial role in nonalcoholic fatty liver disease based on analysis of microarray data","volume":"51","author":"Ma","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"11","key":"10.1016\/j.lfs.2022.120751_bb0125","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1016\/j.bmcl.2007.03.017","article-title":"2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors","volume":"17","author":"Li","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.lfs.2022.120751_bb0130","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.22774","article-title":"Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice","volume":"49","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0135","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/nu9030230","article-title":"Fructose and NAFLD: the multifaceted aspects of fructose metabolism","volume":"9","author":"Jegatheesan","year":"2017","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0140","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jhep.2015.01.019","article-title":"Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds","volume":"62","author":"Xu","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2022.120751_bb0145","series-title":"Role of Allopurinol in the Treatment of Hyperuricemic Patients With Non Alcoholic Fatty Liver Disease","author":"Sylvia","year":"2015"},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5114\/ceh.2019.83159","article-title":"Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats","volume":"5","author":"Khalaf","year":"2019","journal-title":"Clin. Exp. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0155","first-page":"G214","article-title":"CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. American journal of physiology-gastrointestinal and liver","volume":"305","author":"Peterson","year":"2013","journal-title":"Physiology"},{"key":"10.1016\/j.lfs.2022.120751_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cca.2018.01.003","article-title":"Serum CTRP3 level is inversely associated with nonalcoholic fatty liver disease: a 3-y longitudinal study","volume":"479","author":"Zhou","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.lfs.2022.120751_bb0165","first-page":"1568","article-title":"New insights into implications of CTRP3 in obesity, metabolic dysfunction, and cardiovascular diseases: potential of therapeutic interventions","author":"Guo","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.lfs.2022.120751_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101595","article-title":"CTRP3 ameliorates fructose-induced metabolic associated fatty liver disease via inhibition of xanthine oxidase-associated oxidative stress","volume":"72","author":"Zhang","year":"2021","journal-title":"Tissue Cell"},{"key":"10.1016\/j.lfs.2022.120751_bb0175","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3848084","article-title":"Ellagic acid: a review on its natural sources, chemical stability, and therapeutic potential","volume":"2022","author":"Sharifi-Rad","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0180","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.fct.2007.10.043","article-title":"Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats","volume":"46","author":"Tasaki","year":"2008","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120751_bb0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40495-019-00181-w","article-title":"Ellagic acid, kaempferol, and quercetin from Acacia nilotica: promising combined drug with multiple mechanisms of action","volume":"5","author":"Al-Nour","year":"2019","journal-title":"Curr. Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0190","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/tx500065y","article-title":"Ellagic acid: an unusually versatile protector against oxidative stress","volume":"27","author":"Galano","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.lfs.2022.120751_bb0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopha.2016.07.046","article-title":"Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems","volume":"83","author":"Pavlova","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0200","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/ijms22031277","article-title":"Anti-inflammatory effects of ellagic acid on keratinocytes via MAPK and STAT pathways","volume":"22","author":"Gil","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.lfs.2022.120751_bb0205","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1055\/a-0633-9492","article-title":"A pharmacological update of ellagic acid","volume":"84","author":"R\u00edos","year":"2018","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1139\/cjpp-2020-0404","article-title":"Impact of ellagic acid application on doxorubicin-induced cardiovascular toxicity model","volume":"99","author":"Salinger-Martinovic","year":"2021","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13217","article-title":"The preventive effect of ellagic acid on brain damage in rats via regulating of Nrf-2, NF-kB and apoptotic pathway","volume":"44","author":"Aslan","year":"2020","journal-title":"J. Food Biochem."},{"key":"10.1016\/j.lfs.2022.120751_bb0220","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2015.04.008","article-title":"Ellagic acid: pharmacological activities and molecular mechanisms involved in liver protection","volume":"97","author":"Garc\u00eda-Ni\u00f1o","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"43","key":"10.1016\/j.lfs.2022.120751_bb0225","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1021\/acs.jafc.1c05239","article-title":"Ellagic acid exerts beneficial effects on hyperuricemia by inhibiting xanthine oxidase and NLRP3 inflammasome activation","volume":"69","author":"Sun","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"7","key":"10.1016\/j.lfs.2022.120751_bb0230","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jbt.21418","article-title":"Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats","volume":"26","author":"Kannan","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.lfs.2022.120751_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119673","article-title":"10-dehydrogingerdione ameliorates renal endoplasmic reticulum\/oxidative stress and apoptosis in alcoholic nephropathy induced in experimental rats","volume":"279","author":"Elnagar","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120751_bb0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.biopha.2016.06.032","article-title":"10-DHGD ameliorates cisplatin-induced nephrotoxicity in rats","volume":"83","author":"Elseweidy","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.2008036","article-title":"Validation of the friedewald equation for evaluation of plasma LDL-cholesterol","volume":"43","author":"Fukuyama","year":"2007","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.lfs.2022.120751_bb0250","series-title":"Bancroft's Theory and Practice of Histological Techniques E-Book","author":"Suvarna","year":"2018"},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0255","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/0300985813485099","article-title":"Principles for valid histopathologic scoring in research","volume":"50","author":"Gibson-Corley","year":"2013","journal-title":"Vet. Pathol."},{"issue":"8","key":"10.1016\/j.lfs.2022.120751_bb0260","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v19.i8.1166","article-title":"Fructose as a key player in the development of fatty liver disease","volume":"19","author":"Basaranoglu","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0265","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.lfs.2022.120751_bb0270","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00018-019-03348-2","article-title":"Recent advances in the pathogenesis of hereditary fructose intolerance: implications for its treatment and the understanding of fructose-induced non-alcoholic fatty liver disease","volume":"77","author":"Buziau","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2022.120751_bb0275","first-page":"1198","article-title":"Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats","volume":"54","author":"Ali","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.lfs.2022.120751_bb0280","article-title":"Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental model","volume":"247","author":"Venkatasubramanian","year":"2021","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0285","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jff.2013.01.005","article-title":"Pomegranate husk extract, punicalagin and ellagic acid inhibit fatty acid synthase and adipogenesis of 3T3-L1 adipocyte","volume":"5","author":"Wu","year":"2013","journal-title":"J. Funct. Foods"},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0290","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1016\/j.clnu.2021.01.026","article-title":"Effect of a high fructose diet on metabolic parameters in carriers for hereditary fructose intolerance","volume":"40","author":"Debray","year":"2021","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0295","first-page":"136","article-title":"Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis","volume":"49","author":"Darmawan","year":"2017","journal-title":"Acta Med. Indones."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/medicina55020026","article-title":"Oxidative stress and antioxidant biomarkers in clinical and experimental models of non-alcoholic fatty liver disease","volume":"55","author":"Ore","year":"2019","journal-title":"Medicina"},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5114\/ceh.2018.75955","article-title":"Underrated enemy\u2013from nonalcoholic fatty liver disease to cancers of the gastrointestinal tract","volume":"4","author":"Derra","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0310","first-page":"2398","article-title":"Oxaliplatin aggravates hepatic oxidative stress, inflammation and fibrosis in a non-alcoholic fatty liver disease mouse model","volume":"43","author":"Lu","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120751_bb0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00534-010-0328-7","article-title":"Allopurinol and xanthine oxidase inhibition in liver ischemia reperfusion","volume":"18","author":"Peglow","year":"2011","journal-title":"J. Hepato-Biliary-Pancreatic Sci."},{"issue":"11","key":"10.1016\/j.lfs.2022.120751_bb0320","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11094-018-1724-6","article-title":"The effects of cimetidine, N-acetylcysteine, and taurine on thioridazine metabolic activation and induction of oxidative stress in isolated rat hepatocytes","volume":"51","author":"Eftekhari","year":"2018","journal-title":"Pharm. Chem. J."},{"issue":"09","key":"10.1016\/j.lfs.2022.120751_bb0325","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0042-110178","article-title":"Triazole rizatriptan induces liver toxicity through lysosomal\/mitochondrial dysfunction","volume":"66","author":"Fard","year":"2016","journal-title":"Drug Res."},{"issue":"10","key":"10.1016\/j.lfs.2022.120751_bb0330","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/labinvest.2014.98","article-title":"Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes","volume":"94","author":"Choi","year":"2014","journal-title":"Lab. Investig."},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0335","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1039\/C9FO00284G","article-title":"Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT\/SREBP-1\/FASN pathway","volume":"10","author":"Zhang","year":"2019","journal-title":"Food Funct."},{"issue":"31","key":"10.1016\/j.lfs.2022.120751_bb0340","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1074\/jbc.RA119.008708","article-title":"Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease","volume":"294","author":"Guo","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2022.120751_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2021.100051","article-title":"ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score","volume":"2","author":"Sanjay","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discovery"},{"issue":"10","key":"10.1016\/j.lfs.2022.120751_bb0350","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/biom9100601","article-title":"Allopurinol prevents the lipogenic response induced by an acute oral fructose challenge in short-term fructose fed rats","volume":"9","author":"Garc\u00eda-Arroyo","year":"2019","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.lfs.2022.120751_bb0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","article-title":"CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats","volume":"60","author":"Ma","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.lfs.2022.120751_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133955","article-title":"Lower circulating C1q\/TNF-related protein-3 (CTRP3) levels are associated with obesity: a cross-sectional study","volume":"10","author":"Wolf","year":"2015","journal-title":"PLoS One"},{"issue":"51","key":"10.1016\/j.lfs.2022.120751_bb0365","doi-asserted-by":"crossref","first-page":"39691","DOI":"10.1074\/jbc.M110.180695","article-title":"C1q\/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output","volume":"285","author":"Peterson","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13880209.2021.1990969","article-title":"Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK","volume":"60","author":"ALTamimi","year":"2022","journal-title":"Pharm. Biol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120751_bb0375","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0960327121989412","article-title":"CTRP3 protects hippocampal neurons from oxygen-glucose deprivation-induced injury through the AMPK\/Nrf2\/ARE pathway","volume":"40","author":"Ding","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120751_bb0380","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jep.2009.02.039","article-title":"Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats","volume":"123","author":"Shih","year":"2009","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120751_bb0385","doi-asserted-by":"crossref","first-page":"F1080","DOI":"10.1152\/ajprenal.90767.2008","article-title":"Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement","volume":"297","author":"Hu","year":"2009","journal-title":"Am. J. Physiol.Renal Physiol."},{"key":"10.1016\/j.lfs.2022.120751_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.113814","article-title":"Anti-NAFLD effect of defatted walnut powder extract in high fat diet-induced C57BL\/6 mice by modulating the gut microbiota","volume":"270","author":"Ren","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120751_bb0395","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/pr9030434","article-title":"Co-treatment with cefotaxime and high-fructose diet inducing nonalcoholic fatty liver disease and gut microbial dysbiosis in mice","volume":"9","author":"Lee","year":"2021","journal-title":"Processes"},{"issue":"5","key":"10.1016\/j.lfs.2022.120751_bb0400","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","article-title":"Fructose and hepatic insulin resistance","volume":"57","author":"Softic","year":"2020","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.lfs.2022.120751_bb0405","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.lfs.2019.03.078","article-title":"Ellagic acid protects against diabetes-associated behavioral deficits in rats: possible involved mechanisms","volume":"225","author":"Farbood","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120751_bb0410","series-title":"Mechanisms by Which Dietary Ellagic Acid Attenuates Obesity and Obesity-mediated Metabolic Complications","author":"Kang","year":"2015"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:01Z","timestamp":1758402121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522004519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":82,"alternative-id":["S0024320522004519"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120751","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q\/tumor necrosis factor-related protein-3 and ATP citrate lyase","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120751"}}